SIMPRE Trademark

Trademark Overview

On Tuesday, December 12, 2023, a trademark application was filed for SIMPRE with the United States Patent and Trademark Office. The USPTO has given the SIMPRE trademark a serial number of 98310562. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, February 24, 2025. This trademark is owned by Sanofi. The SIMPRE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of multiple myeloma
simpre

General Information

Serial Number98310562
Word MarkSIMPRE
Filing DateTuesday, December 12, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, February 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of multiple myeloma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParis 75017
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75017
FR

Trademark Events

Event DateEvent Description
Friday, December 15, 2023NEW APPLICATION ENTERED
Wednesday, December 27, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, January 26, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 26, 2024ASSIGNED TO LIE
Thursday, July 11, 2024ASSIGNED TO EXAMINER
Saturday, July 13, 2024NON-FINAL ACTION WRITTEN
Saturday, July 13, 2024NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, July 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 20, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, July 13, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 20, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 24, 2025SOU TEAS EXTENSION RECEIVED
Monday, February 24, 2025SOU EXTENSION 1 FILED
Monday, February 24, 2025SOU EXTENSION 1 GRANTED
Monday, February 24, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 30, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, June 30, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

simpre preparations pharmaceutical treatment myeloma multiple cancer oncology